Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
Demo Company
GLOBETECH PUBLISHING LLC

New Microplate Designed for High-Resolution Microscopy

By BiotechDaily International staff writers
Posted on 12 Mar 2013
Image: The new 96-well “ScreenStar” microplate for high-resolution microscopy (Photo courtesy of Greiner Bio-One).
Image: The new 96-well “ScreenStar” microplate for high-resolution microscopy (Photo courtesy of Greiner Bio-One).
A new, black 96-well microplate includes an ultra-low well base that enables high-magnification microscopy, inclusive of perimeter wells, even with a minimum working distance.

Greiner Bio-One (Frickenhausen, Germany) now expands its microplate portfolio with the introduction of “ScreenStar” at the 2013 Society for Laboratory Automation and Screening (SLAS) conference exhibition in Orlando (FL, USA). The ScreenStar design includes several new features. Manufactured entirely of cycloolefin, an innovative material with glass-like optical properties, it facilitates outstanding image quality of well contents. The microplate has a 190 μm ultraclear film bottom. The key advantage of ScreenStar over other plates for high-resolution microscopy is the extremely short distance between the well bottom and the microplate skirt (internal well to skirt bottom = 0.7 mm; external well to skirt bottom = 0.51 mm), rendering ease of high magnification microscopy at perimeter wells without complex microscopic adjustments. The circular wells allow microscopic work without disruptive shadow using the smallest possible meniscus lens. The perimeter ditch can be filled with water or medium to reduce edge effect due to evaporation, especially for long incubation periods. A proven cell culture-treatment quality ensures reliable, uniform growth.

The black, 96-well, 190 μm clear film bottom, cell culture treated, cycloolefin ScreenStar microplate comes sterile with lid, individually packed. Well bottoms are protected by a film that must be removed prior to use. The identical microscopy plate with a glass bottom will be introduced shortly.

Related Links:
Greiner Bio-One



Channels

Business

view channel

MS Drug Deal to Net More Than USD 1 Billion

A pharmaceutical company based in Switzerland has purchased the remaining rights to the multiple sclerosis drug Ofatumumab, which will allow it to continue development of the compound for treating relapsing remitting multiple sclerosis (RRMS) and similar autoimmune diseases. Novartis (Basel, Switzerland) recently announced... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.